Management tracks: Fred Hutch taps BMS CSO Lynch; plus GSK, Rubius, Provention, Antengene, Revitope, Compugen, Wellington, Adamas, Arcturus and Turnstone

Fred Hutchinson Cancer Research Center hired Thomas Lynch as president and director, effective next month. Lynch was CSO of Bristol-Myers Squibb Co. (NYSE:BMY). He succeeds Gary Gilliland, who announced in September his plans to step down.

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said ViiV Healthcare Ltd. CEO Deborah Waterhouse will join the pharma’s corporate executive team. Before joining ViiV, which is an HIV-focused JV of GSK, Pfizer Inc. (NYSE:PFE) and Shionogi & Co. Ltd. (Tokyo:4507), Waterhouse was SVP and business unit head of primary care at GSK...